{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:06:23Z","timestamp":1783922783389,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,12]]},"DOI":"10.7759\/cureus.112551","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:20:52Z","timestamp":1783920052000},"source":"Crossref","is-referenced-by-count":0,"title":["Recurrent Pleural Effusion and Grade 3 Pyrophosphate Uptake in Cardiac Immunoglobulin Light Chain (AL) Amyloidosis: A Transthyretin Amyloidosis (ATTR) Phenocopy"],"prefix":"10.7759","author":[{"given":"Amanda","family":"Carreon Simental","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Villanueva-Lechuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonor","family":"Bonilla Quezada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Aldo","family":"Sanchez Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Martinez-Mijares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar AD","year":"2016","unstructured":"Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet. 2016, 387:2641-54. 10.1016\/S0140-6736(15)01274-X","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2304088","article-title":"Systemic light chain amyloidosis","volume":"390","author":"Sanchorawala V","year":"2024","unstructured":"Sanchorawala V. Systemic light chain amyloidosis. N Engl J Med. 2024, 390:2295-307. 10.1056\/NEJMra2304088","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1378\/chest.124.3.969","article-title":"Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis","volume":"124","author":"Berk JL","year":"2003","unstructured":"Berk JL, Keane J, Seldin DC, Sanchorawala V, Koyama J, Dember LM, Falk RH. Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis. Chest. 2003, 124:969-77. 10.1378\/chest.124.3.969","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore JD","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH, et al.. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016, 133:2404-12. 10.1161\/CIRCULATIONAHA.116.021612","journal-title":"Circulation"},{"key":"ref5","article-title":"Criteria Committee of the New York Heart Association: Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels","author":"Criteria Committee of the New York Heart Association","year":"1994","unstructured":"Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels, 9th Edition. Little, Brown and Co, Boston, MA; 1994. https:\/\/search.worldcat.org\/title\/nomenclature-and-criteria-for-diagnosis-of-diseases-of-the-heart-and-great-vessels\/...."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer M","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, et al.. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019, 71:1400-12. 10.1002\/art.40930","journal-title":"Arthritis Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(49)90562-1","article-title":"The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads","volume":"37","author":"Sokolow M","year":"1949","unstructured":"Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949, 37:161-86. 10.1016\/0002-8703(49)90562-1","journal-title":"Am Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(85)80115-7","article-title":"Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria","volume":"6","author":"Casale PN","year":"1985","unstructured":"Casale PN, Devereux RB, Kligfield P, Eisenberg RR, Miller DH, Chaudhary BS, Phillips MC. Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol. 1985, 6:572-80. 10.1016\/S0735-1097(85)80115-7","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.01.037","article-title":"Electrocardiographic criteria for the diagnosis of left ventricular hypertrophy","volume":"69","author":"Peguero JG","year":"2017","unstructured":"Peguero JG, Lo Presti S, Perez J, Issa O, Brenes JC, Tolentino A. Electrocardiographic criteria for the diagnosis of left ventricular hypertrophy. J Am Coll Cardiol. 2017, 69:1694-703. 10.1016\/j.jacc.2017.01.037","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini E","year":"2005","unstructured":"Perugini E, Guidalotti PL, Salvi F, et al.. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol. 2005, 46:1076-84. 10.1016\/j.jacc.2005.05.073","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.24875\/ACM.M24000097","article-title":"Mexican position paper for the diagnosis and treatment of cardiac amyloidosis","volume":"94","author":"Berrios-B\u00e1rcenas EA","year":"2024","unstructured":"Berrios-B\u00e1rcenas EA, Cigarroa-L\u00f3pez JA, Cossio-Aranda JE, et al.. Mexican position paper for the diagnosis and treatment of cardiac amyloidosis. Arch Cardiol Mex. 2024, 94:1-33. 10.24875\/ACM.M24000097","journal-title":"Arch Cardiol Mex"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar SV","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, et al.. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014, 15:e538-48. 10.1016\/S1470-2045(14)70442-5","journal-title":"Lancet Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements","volume":"30","author":"Kumar S","year":"2012","unstructured":"Kumar S, Dispenzieri A, Lacy MQ, et al.. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol. 2012, 30:989-95. 10.1200\/JCO.2011.38.5724","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-12-473066","article-title":"A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis","volume":"121","author":"Wechalekar AD","year":"2013","unstructured":"Wechalekar AD, Schonland SO, Kastritis E, et al.. A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis. Blood. 2013, 121:3420-7. 10.1182\/blood-2012-12-473066","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia P","year":"2021","unstructured":"Garcia-Pavia P, Rapezzi C, Adler Y, et al.. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2021, 42:1554-68. 10.1093\/eurheartj\/ehab072","journal-title":"Eur Heart J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcp.0000162378.35928.37","article-title":"Pleural effusions in systemic amyloidosis","volume":"11","author":"Berk JL","year":"2005","unstructured":"Berk JL. Pleural effusions in systemic amyloidosis. Curr Opin Pulm Med. 2005, 11:324-8. 10.1097\/01.mcp.0000162378.35928.37","journal-title":"Curr Opin Pulm Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01698-7","article-title":"Prognostic implications of pericardial and pleural effusion in patients with cardiac amyloidosis","volume":"110","author":"Binder C","year":"2021","unstructured":"Binder C, Duca F, Binder T, et al.. Prognostic implications of pericardial and pleural effusion in patients with cardiac amyloidosis. Clin Res Cardiol. 2021, 110:532-43. 10.1007\/s00392-020-01698-7","journal-title":"Clin Res Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis","volume":"1","author":"Castano A","year":"2016","unstructured":"Castano A, Haq M, Narotsky DL, et al.. Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis. JAMA Cardiol. 2016, 1:880-9. 10.1001\/jamacardio.2016.2839","journal-title":"JAMA Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jeab095","article-title":"99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis","volume":"22","author":"Quarta CC","year":"2021","unstructured":"Quarta CC, Zheng J, Hutt D, et al.. 99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2021, 22:1304-11. 10.1093\/ehjci\/jeab095","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2 - evidence base and standardized methods of imaging","volume":"26","author":"Dorbala S","year":"2021","unstructured":"Dorbala S, Ando Y, Bokhari S, et al.. ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2 - evidence base and standardized methods of imaging. J Nucl Cardiol. 2021, 26:2065-123. 10.1007\/s12350-019-01760-6","journal-title":"J Nucl Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/510253-recurrent-pleural-effusion-and-grade-3-pyrophosphate-uptake-in-cardiac-immunoglobulin-light-chain-al-amyloidosis-a-transthyretin-amyloidosis-attr-phenocopy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:20:53Z","timestamp":1783920053000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/510253-recurrent-pleural-effusion-and-grade-3-pyrophosphate-uptake-in-cardiac-immunoglobulin-light-chain-al-amyloidosis-a-transthyretin-amyloidosis-attr-phenocopy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,12]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.112551","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,12]]}}}